Matches in SemOpenAlex for { <https://semopenalex.org/work/W2772039704> ?p ?o ?g. }
Showing items 1 to 62 of
62
with 100 items per page.
- W2772039704 abstract "Lack of a reliable animal hindlimb gangrene model limits molecular investigation of critical limb ischemia. We sought to develop a mouse hindlimb gangrene model, used to assess the efficacy of novel gene therapy. We hypothesized that priming ischemic hindlimb tissue with E-selectin/adeno-associated virus (AAV) enhances therapeutic angiogenesis and attenuates gangrene. We tested two methods to induce hindlimb gangrene. First, FVB mice underwent femoral artery ligation (FAL) to achieve critical limb ischemia. Second, FVB underwent combined FAL and administration of NG-nitro-L-arginine methyl ester (L-NAME), nitric oxide synthase inhibitor, which further reduces hindlimb perfusion. Prior to FAL and L-NAME use, gangrene-induced mice were intramuscularly administered E-selectin/AAV (treatment) or LacZ/AAV (control) to the hindlimb. Gangrene was assessed with a standardized ischemia score ranging from 0 (no gangrene) to 11 (forefoot gangrene), recorded on postoperative day (POD)’s 2,7,14. Hindlimb reperfusion using Laser doppler imaging was quantified by mean perfusion of ligated:non-ligated limb on same POD’s. Live animal Dil perfusion plus laser scanning confocal microscopy quantified limb neovascularization. Most FVB did not develop gangrene with FAL-only (n=2/8, 25% gangrene incidence). Combined FAL and L-NAME consistently induced hindlimb gangrene (n=14/14, 100% gangrene incidence). Laser doppler imaging score on POD 7 for E-selectin/AAV (n=7) and LacZ/AAV (n=7) was 0.41 vs 0.27 (P=0.071) and on POD 14 was 0.54 vs 0.29 (P=0.017). Dil perfused ligated hindlimb in E-selectin/AAV and LacZ/AAV revealed significantly higher mean neovascularization intensity score of 44 vs 21 (P=0.037). Dil perfused non-ligated limb in respective mice demonstrated mean intensity score of 50 vs 25 (P=0.006). Mean limb ischemia score on POD 2,7,14 for E-selectin/AAV and LacZ/AAV was 1.9, 2.9, 3.7 vs 2.7, 3.9, 5.3 (P=0.104). We developed a highly reliable mouse hindlimb gangrene model where E-selectin-based novel gene therapy improved limb reperfusion and neovascuclarization in critical limb ischemia. This hindlimb gangrene model can be used to further understand Redox pathways contributing to gangrene, facilitating future translational studies." @default.
- W2772039704 created "2017-12-22" @default.
- W2772039704 creator A5008748418 @default.
- W2772039704 creator A5033528741 @default.
- W2772039704 creator A5038805449 @default.
- W2772039704 creator A5050778675 @default.
- W2772039704 creator A5051881896 @default.
- W2772039704 creator A5066716259 @default.
- W2772039704 creator A5069811393 @default.
- W2772039704 date "2017-05-01" @default.
- W2772039704 modified "2023-09-27" @default.
- W2772039704 title "Abstract 475: Novel Gene Therapy Facilitates Critical Limb Ischemia Reperfusion in Mouse Hindlimb Gangrene Model" @default.
- W2772039704 doi "https://doi.org/10.1161/atvb.37.suppl_1.475" @default.
- W2772039704 hasPublicationYear "2017" @default.
- W2772039704 type Work @default.
- W2772039704 sameAs 2772039704 @default.
- W2772039704 citedByCount "0" @default.
- W2772039704 crossrefType "journal-article" @default.
- W2772039704 hasAuthorship W2772039704A5008748418 @default.
- W2772039704 hasAuthorship W2772039704A5033528741 @default.
- W2772039704 hasAuthorship W2772039704A5038805449 @default.
- W2772039704 hasAuthorship W2772039704A5050778675 @default.
- W2772039704 hasAuthorship W2772039704A5051881896 @default.
- W2772039704 hasAuthorship W2772039704A5066716259 @default.
- W2772039704 hasAuthorship W2772039704A5069811393 @default.
- W2772039704 hasConcept C126322002 @default.
- W2772039704 hasConcept C141071460 @default.
- W2772039704 hasConcept C142724271 @default.
- W2772039704 hasConcept C146957229 @default.
- W2772039704 hasConcept C2776626339 @default.
- W2772039704 hasConcept C2779723990 @default.
- W2772039704 hasConcept C51738704 @default.
- W2772039704 hasConcept C541997718 @default.
- W2772039704 hasConcept C71924100 @default.
- W2772039704 hasConceptScore W2772039704C126322002 @default.
- W2772039704 hasConceptScore W2772039704C141071460 @default.
- W2772039704 hasConceptScore W2772039704C142724271 @default.
- W2772039704 hasConceptScore W2772039704C146957229 @default.
- W2772039704 hasConceptScore W2772039704C2776626339 @default.
- W2772039704 hasConceptScore W2772039704C2779723990 @default.
- W2772039704 hasConceptScore W2772039704C51738704 @default.
- W2772039704 hasConceptScore W2772039704C541997718 @default.
- W2772039704 hasConceptScore W2772039704C71924100 @default.
- W2772039704 hasIssue "suppl_1" @default.
- W2772039704 hasLocation W27720397041 @default.
- W2772039704 hasOpenAccess W2772039704 @default.
- W2772039704 hasPrimaryLocation W27720397041 @default.
- W2772039704 hasRelatedWork W1202594152 @default.
- W2772039704 hasRelatedWork W2021087981 @default.
- W2772039704 hasRelatedWork W2060539584 @default.
- W2772039704 hasRelatedWork W2085696749 @default.
- W2772039704 hasRelatedWork W2383725167 @default.
- W2772039704 hasRelatedWork W2383963302 @default.
- W2772039704 hasRelatedWork W2386511007 @default.
- W2772039704 hasRelatedWork W2392948703 @default.
- W2772039704 hasRelatedWork W2977586112 @default.
- W2772039704 hasRelatedWork W58290344 @default.
- W2772039704 hasVolume "37" @default.
- W2772039704 isParatext "false" @default.
- W2772039704 isRetracted "false" @default.
- W2772039704 magId "2772039704" @default.
- W2772039704 workType "article" @default.